Lori Hazlehurst

5.9k citations
91 papers · 4.6k indexed · 1 hit paper · h-index 35
Topics
Multiple Myeloma Research and Treatments (29 papers)Cell Adhesion Molecules Research (12 papers)Cancer therapeutics and mechanisms (11 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Lori Hazlehurst

88 papers receiving 4.5k citations

Hit Papers

Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of ...19992026200820171999200400600

Peers

Lori Hazlehurst
Comparison fields: 5 of 111
  • Molecular Biology 2.5k
  • Oncology 1.9k
  • Hematology 1.7k
  • Immunology 575
  • Cancer Research 557
Replace Ellen Weisberg with:
Ellen Weisberg United States
Peter Blume‐Jensen United States
Terry H. Landowski United States
Emma Shtivelman United States
Laura K. Shawver United States
Joel Johansson United States
Suzanne Trudel Canada
A Levitzki Israel
Joaquı́n Arribas Spain
Marc S. Raab Germany
Lori Hazlehurst relative to Ellen Weisberg United States Ellen Weisberg's profile →
Citations per field
00.5×
Ellen Weisberg · 1×
Citations per year

Countries citing papers authored by Lori Hazlehurst

Since Specialization
Citations

This map shows the geographic impact of Lori Hazlehurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Hazlehurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Hazlehurst more than expected).

Fields of papers citing papers by Lori Hazlehurst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Hazlehurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Hazlehurst. The network helps show where Lori Hazlehurst may publish in the future.

Co-authorship network of co-authors of Lori Hazlehurst

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Hazlehurst. A scholar is included among the top collaborators of Lori Hazlehurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Hazlehurst. Lori Hazlehurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 6
3 1
4 2
5 0
6 23
7 6
8 2
9 6
10 10
11 3
12 33
13 21
14 42
15 24
16 90
17 33
18
Bone marrow stromal cells activate Stat3 and confer resistance to Bcr-Abl inhibitors in K562 CML cells
0
19 162
20 132

About Lori Hazlehurst

Lori Hazlehurst is a scholar working on Hematology, Immunology and Allergy and Oncology, having authored 91 papers that have together received 4.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Cell Adhesion Molecules Research (12 papers) and Cancer therapeutics and mechanisms (11 papers). The work is most often cited by research in Hematology (1.7k citations), Immunology and Allergy (555 citations) and Oncology (1.9k citations). Lori Hazlehurst has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include William S. Dalton, William S. Dalton, Jason S. Damiano, Anne E. Cress, Mark B. Meads, Аlexander А. Shtil, Rajesh R. Nair, David Boulware, Michael F. Emmons and Terry H. Landowski. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026